US antivirals giant Gilead Sciences (Nasdaq: GILD) yesterday announced a substantial investment plan, noting that it is ...

The American medicines regulator will convene its vaccine advisory committee on May 22 to weigh in on which strains should be ...

Japanese drugmaker Shionogi (TYO: 4507) is to scale up its pipeline and global ambitions with a deal worth more than $1 ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Tepezza (teprotumumab (Tepezza). This ...

Pharmaceutical and Research Manufacturers of America (PhRMA) yesterday submitted comments to the US Department of Commerce on ...

US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.

Israel’s Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today reported results for the quarter ended March 31, 2025.

Trade group the Association of the British Pharmaceutical Industry (ABPI) has spoken out against a new free trade agreement signed by the UK government with India.

US President Donald Trump has signed an executive order attempting to restore a robust domestic manufacturing base for ...

A Seattle-based preclinical biotech comany developing novel neuroplastogens to treat neuropsychiatric and neurodegenerative ...

Sino American biotech BeiGene (Nasdaq: ONC; HKEX: 06160), a global oncology company that will change its name to BeOne ...

UK-based pharma major AstraZeneca and its Japanese partner Daiichi Sankyo are moving to expand the reach of their blockbuster ...